Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,660 | 3,097 | 7,035 | 2,946 | 3,084 |
| Marketable Securities | 9,993 | 12,351 | 11,272 | 13,736 | 16,882 |
| Receivables | 336 | 284 | 366 | 479 | 256 |
| TOTAL | $11,989 | $15,732 | $18,673 | $17,161 | $20,222 |
| Non-Current Assets | |||||
| PPE Net | 665 | 718 | 791 | 840 | 859 |
| TOTAL | $665 | $718 | $791 | $840 | $859 |
| Total Assets | $12,654 | $16,450 | $19,464 | $18,001 | $21,081 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,734 | 3,485 | 1,815 | 3,353 | 3,024 |
| TOTAL | $3,819 | $4,579 | $2,860 | $3,353 | $3,024 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,085 | 1,094 | 1,045 | N/A | N/A |
| Other Non-Current Liabilities | 267 | 267 | 222 | 222 | 177 |
| TOTAL | $537 | $796 | $1,074 | $222 | $177 |
| Total Liabilities | $4,356 | $5,375 | $3,934 | $3,575 | $3,201 |
| Shareholders' Equity | |||||
| Common Shares | 34 | 34 | 34 | 32 | 32 |
| Retained earnings | -67,482 | -64,320 | -59,494 | -55,662 | -51,351 |
| Other shareholders' equity | -61 | -85 | -135 | -104 | -160 |
| TOTAL | $8,298 | $11,075 | $15,530 | $14,426 | $17,880 |
| Total Liabilities And Equity | $12,654 | $16,450 | $19,464 | $18,001 | $21,081 |